I wonder if our SET team sends thank you cards to Janssen

[anonymous]

Imagine if Janssen was still promoting Invokana. Say whatever you want about the boxed warning it received, providers would still be prescribing the drug if it was still being promoted. With that said, Farxiga still can't get 30% Market Share nationally on a consistent basis. I send thank you cards all the time to Janssen for saving my job. When will management realize, providers do not give a shit about our CKD indication. They are treating diabetes. Farxiga would be lucky to be at 20% market share nationally if Invokana was still in the mix